Skip to main content
OpenTrials

Clinical trial condition

Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Explore clinical trials studying Primary Mediastinal Large B-cell Lymphoma (PMBCL). Study availability and eligibility vary by location and protocol.

21 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Primary Mediastinal Large B-cell Lymphoma (PMBCL) trial results

Recruiting

Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors

NCT05934084

Conditions
Behavior, Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), +13 more
Locations
  • Ancona - AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy
  • Aviano - IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati Aviano, Italy
  • Istituto Tumori Bari Giovanni Paolo II, U.O. di Ematologia e Terapia Cellulare Bari, Italy
  • Ospedale S. Martino - UOC Oncologia Belluno, Italy
View all 40 locations
View Trial Details
Completed

Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study

NCT05162170

Conditions
Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Locations
  • U.F. Oncoematologia, IOM (Istituto Oncologico del Mediterraneo) Viagrande, Catania, Italy
  • SC Ematologia, A.O. SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Clinica di Ematologia, AOU Ospedali Riuniti Ancona, Italy
  • Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy
View all 40 locations
View Trial Details
Completed

A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

NCT04875195

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +8 more
Locations
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site Torrance, California, United States
  • Tulane Medical Center ( Site 0110) New Orleans, Louisiana, United States
  • Anne Arundel Medical Center-Anne Arundel Oncology and Hematology ( Site 0125) Annapolis, Maryland, United States
  • Hospital Erasto Gaertner ( Site 1703) Curitiba, Paraná, Brazil
View all 27 locations
View Trial Details
Active, Not Recruiting

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

NCT03625037

Conditions
Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), Chronic Disease, DLBCL, +26 more
Locations
  • Arizona Mayo Clinic Phoenix, Arizona, United States
  • University of California at San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 85 locations
View Trial Details
Active, Not Recruiting

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

NCT06014762

Conditions
DLBCL, DLBCL - Diffuse Large B Cell Lymphoma, DLBCL Arising From Follicular Lymphoma, +21 more
Locations
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Advent Health Orlando Orlando, Florida, United States
  • Indiana University Indianapolis, Indiana, United States
View all 16 locations
View Trial Details

Related conditions